FDA-Approved Weight Loss Treatments: Your Ultimate Guide

With obesity and excess weight impacting millions of Americans, the demand for safe and effective weight loss solutions has never been higher. While healthy eating and regular exercise remain fundamental, many individuals require medically supervised treatments to help achieve and maintain a healthier weight. Over the past decade, the U.S. Food and Drug Administration (FDA) has approved a growing number of prescription medications designed to support chronic weight management. In this guide, we’ll cover the leading FDA-approved weight loss medications, how they work, who can benefit, what results to expect, and answers to the most common questions.

Overview: Why Weight Loss Medications?

Obesity is linked to several leading causes of death, including heart disease, stroke, type 2 diabetes, and certain cancers. For individuals struggling to lose weight through lifestyle changes alone, medications can provide significant additional support—especially for those with obesity-related health conditions.

  • Nearly 70% of American adults have overweight or obesity. Many lack effective non-surgical options for lasting weight loss .
  • Weight loss of 5% to 10% through diet, exercise, and medication can reduce risk of major illnesses .

Who Qualifies for Prescription Weight Loss Medication?

Not everyone is a candidate for these medications. FDA approval generally requires that patients meet specific criteria:

  • Adults with a BMI ≥30 (classified as obese).
  • Adults with a BMI ≥27 with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol) .
  • Some medications are approved for children or teens with severe obesity (see medication chart below) .

How Do Weight Loss Medications Work?

Weight loss drugs may act by:

  • Suppressing appetite
  • Reducing absorption of fat
  • Altering metabolism or food cravings
  • Targeting hormonal pathways involved in hunger and fullness

When prescribed, these medications should be used in addition to a nutritious diet and increased physical activity for optimal results .

Current FDA-Approved Weight Loss Medications

The following medications are most commonly prescribed for chronic weight management. Each has distinct mechanisms and eligibility criteria.

Medication Name Brand Names Who Can Use Formulation Dosage Frequency
Semaglutide Wegovy, Ozempic (off-label) Adults, Children 12+ Injection Once weekly
Tirzepatide Zepbound, Mounjaro (off-label) Adults Injection Once weekly
Liraglutide Saxenda Adults, Children 12+ Injection Once daily
Phentermine Adipex, Suprenza, Lomaira Age 17+ Tablet, Capsule, ODT Daily (Lomaira: 3x/day)
Phentermine-topiramate Qsymia Adults, Children 12+ Capsule Once daily
Naltrexone-bupropion Contrave Adults Tablet Once or twice daily
Orlistat Xenical, Alli Adults, Children 12+ Capsule 3x/day
Setmelanotide Imcivree Adults, Children 6+ with rare genetic obesity Injection Once daily
Plenity (medical device) Plenity Adults Capsule Twice daily

Highlights of Notable Medications

Wegovy (Semaglutide)

Wegovy is a once-weekly injectable GLP-1 agonist shown to produce weight loss of 10–15% of body weight in many patients . It is the gold standard in current prescription weight loss therapy. Semaglutide is also available as Ozempic, approved for diabetes, but frequently prescribed off-label for weight loss, especially when Wegovy is unavailable or insurance coverage is an issue .

Zepbound (Tirzepatide)

Zepbound is the first dual GIP and GLP-1 agonist approved by the FDA for weight management. In clinical trials, it led to average weight loss up to 22% of baseline body weight . The medication is injected once weekly. Prior to Zepbound’s approval, its diabetes-focused counterpart Mounjaro was used off-label for weight loss .

Saxenda (Liraglutide)

Saxenda is a daily GLP-1 receptor agonist injection, approved for use in adults and adolescents (aged 12 years and older). It generally results in modest weight loss (4–8%) when combined with diet and exercise .

Phentermine & Qsymia

  • Phentermine is an oral stimulant and appetite suppressant, typically prescribed for short-term use due to risk of dependency and cardiovascular side effects .
  • Qsymia combines phentermine with topiramate for greater and more sustained weight loss; approved for extended use .

Contrave (Naltrexone/Bupropion)

Contrave contains bupropion (an antidepressant) and naltrexone (used for addiction). It targets reward-related hunger cravings, producing modest weight loss (about 5–9% of body weight), but may have mood-related side effects .

Orlistat (Xenical, Alli)

  • Orlistat blocks the absorption of fat in your diet. Prescription-strength Xenical and the only FDA-approved over-the-counter version, Alli, are available .
  • May produce 5–10 pounds of weight loss on average. Side effects include gastrointestinal issues and reduced absorption of fat-soluble vitamins.

Setmelanotide (Imcivree)

This medication is reserved for rare genetic obesity syndromes and is not widely prescribed for general obesity management .

Plenity

Plenity is a medical device, not a drug. It swells in the stomach to promote early fullness and reduce caloric intake .

Emerging Treatments & What’s Next

A new generation of weight loss medications is in development, with promising results in clinical trials .

  • Retatrutide: Targets three hormone receptors, offering average weight loss up to 24% in early studies. Not yet FDA approved (as of 2025) .
  • Orforglipron: An oral (pill) GLP-1 agonist showing results similar to injectables, with 10% weight loss in trials .
  • CagriSema, Amycretin, Maritide: Combination therapies and next-gen injectables in advanced trials aim to increase effectiveness and reduce side effects .

Researchers and clinicians are excited about these emerging options, as obesity is a complex condition requiring multi-pathway interventions .

Are These Medications Right for You?

  • These treatments are not suitable for everyone. A healthcare provider’s evaluation is essential, including medical history, current medications, and long-term weight management goals.
  • Drugs are generally prescribed only when lifestyle changes alone have not succeeded and the patient’s BMI and health conditions meet FDA criteria .
  • Many people achieve best results by combining medication with diet and physical activity.

Potential Side Effects and Risks

All weight loss medications can have side effects—some mild, some more serious. It’s crucial to discuss these risks with your provider.

  • GLP-1 and GIP agonists (Wegovy, Zepbound, Saxenda): Most common are nausea, vomiting, and diarrhea. Rarely, risk of pancreatitis, gallbladder disease, or thyroid tumors.
  • Phentermine: Insomnia, dry mouth, elevated heart rate and blood pressure; dependency risk if used long term.
  • Orlistat: Gastrointestinal symptoms, fat-soluble vitamin malabsorption.
  • Contrave: Headache, insomnia, increased risk for mood changes or suicidal thoughts.

Your healthcare provider will monitor for these risks, adjust dosage, and select the best agent for you.

What About Over-the-Counter (OTC) Medications?

  • Alli (orlistat) is the only FDA-approved OTC weight loss product for chronic management .
  • Most other OTC supplements lack proven effectiveness or FDA oversight; some may be harmful.

How Effective Are These Medications Long-Term?

Medications provide significant support but are rarely a permanent ‘cure.’ Many patients experience some weight gain after stopping treatment unless continued with lifestyle changes . For lasting benefits:

  • Stay engaged with medical follow-up and behavioral support.
  • Use medications as part of a comprehensive wellness strategy.

Frequently Asked Questions (FAQs)

Q: How much weight can I expect to lose on prescription medication?

A: Results vary by drug, dose, and individual factors. On average, GLP-1 agonists achieve weight loss of 10–15% (Wegovy) or up to 22% (Zepbound). Older drugs may produce modest 5–9% reductions .

Q: Is Wegovy the same as Ozempic?

A: Both contain semaglutide. Wegovy is FDA-approved for weight loss; Ozempic is FDA-approved for diabetes but often prescribed off-label for weight loss .

Q: Are any oral (pill) weight loss medications available?

A: Yes. Orlistat (Xenical, Alli), Contrave, and Phentermine-topiramate (Qsymia) are FDA-approved oral options. Newer oral agents like Orforglipron are in clinical trials .

Q: Can teenagers use these medications?

A: Some, such as Saxenda, Wegovy, and Qsymia, are FDA-approved for use in children and adolescents over 12 years (Qsymia: 12+; Saxenda and Wegovy: 12+) . Always consult a pediatric specialist.

Q: Are weight loss drugs covered by insurance?

A: Coverage varies. Wegovy and Zepbound may be covered for qualifying patients, but some plans exclude weight loss drugs. Check with your insurance provider and ask about discount programs.

Q: What happens if I stop the medication?

A: Most people regain some or all lost weight unless diet and activity changes are maintained. Ongoing support is recommended .

Takeaway: Making Decisions About Medical Weight Loss

FDA-approved weight loss medications can make a major difference for individuals struggling with obesity and related health risks. Discuss all options—risks, benefits, effectiveness, and lifestyle changes—with your healthcare provider to develop the best plan for long-term health and wellness.

  • Medications are only one part of the solution. Sustained lifestyle habits matter most.
  • Speak to your doctor about which options suit your unique health needs.
  • Stay informed: New drugs and research are rapidly transforming obesity care each year.